Andlauer Healthcare Group Inc.
AND.TO
TSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -1.43% | -1.11% | 0.17% | -1.81% | -5.02% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -1.43% | -1.11% | 0.17% | -1.81% | -5.02% |
Cost of Revenue | -1.96% | -1.49% | -0.09% | -1.39% | -4.00% |
Gross Profit | -0.38% | -0.36% | 0.69% | -2.65% | -7.00% |
SG&A Expenses | 5.33% | 1.99% | 0.82% | 2.40% | -0.33% |
Depreciation & Amortization | -1.99% | 2.55% | 4.09% | 4.87% | 4.05% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -1.28% | -0.67% | 0.51% | -0.28% | -2.71% |
Operating Income | -2.30% | -3.69% | -1.76% | -10.03% | -16.65% |
Income Before Tax | 1.94% | -4.15% | -2.74% | -9.54% | -16.38% |
Income Tax Expenses | -5.21% | -4.50% | -0.31% | -7.58% | -13.93% |
Earnings from Continuing Operations | 4.61% | -4.02% | -3.62% | -10.25% | -17.26% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 4.61% | -4.02% | -3.62% | -10.25% | -17.26% |
EBIT | -2.30% | -3.69% | -1.76% | -10.03% | -16.65% |
EBITDA | -3.36% | 5.22% | -10.33% | -14.61% | -12.18% |
EPS Basic | 9.62% | -0.43% | -0.95% | -9.18% | -16.72% |
Normalized Basic EPS | 1.14% | -0.57% | -0.06% | -8.48% | -15.84% |
EPS Diluted | 10.85% | -0.19% | -1.43% | -9.45% | -16.86% |
Normalized Diluted EPS | 1.65% | -0.11% | 0.07% | -8.39% | -15.80% |
Average Basic Shares Outstanding | -4.48% | -3.49% | -2.66% | -1.14% | -0.61% |
Average Diluted Shares Outstanding | -4.91% | -3.90% | -2.78% | -1.26% | -0.68% |
Dividend Per Share | 18.31% | 21.67% | 23.93% | 25.27% | 26.35% |
Payout Ratio | 0.07% | 0.21% | 0.24% | 0.37% | 0.52% |